Psychosis

Structural racism in the United States has had a significant effect on psychosis risk at the individual and neighborhood levels, according to results of a review paper published in American Journal of Psychiatry.

Rapid screening tools for psychotic disorders available in the DSM-5 had potential clinical utility, according to study results published in Journal of Clinical Psychiatry.

Certain cognitive deficits in childhood were distinctively linked to different psychopathological symptoms among young people, according to results of a cohort study published in JAMA Network Open.

Next-generation sequencing may help identify gene variants linked to inborn errors of metabolism among a subgroup of patients with psychosis, according to study results published in Journal of Psychiatric Research.

A brief blended digital therapy that targets reasoning appeared to have a beneficial effect on paranoia among individuals with psychosis, according to results of a randomized clinical trial published in JAMA Psychiatry.

Acadia Pharmaceuticals has received a complete response letter from the FDA stating that the administration cannot approve a supplemental new drug application for pimavanserin.

Duration of untreated psychosis may serve as an important prognostic factor at first presentation, as well as predict clinically relevant outcomes over the course of illness, according to study results published in World Psychiatry.

Changes in insulin sensitivity and adiposity beginning in childhood appeared to have disorder-specific links to psychosis and depression, according to study results published in JAMA Psychiatry.

Individuals with psychosis were more likely to have a higher prevalence of a particular antibody vs. controls, according to results of a meta-analysis published in The Lancet Psychiatry.

Healio Psychiatry has compiled a list of its five most-viewed stories in December.